Brian D Peyser

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 3

Top Venues

Molecular cancer therapeutics

ACS infectious diseases

National Cancer Institute

Johns Hopkins School of Medicine (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Cancer Institute Dec 03 2012

United States

Coordinator for Computational Drug Development/Special Assisitant to the Associate Director :: Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis

Education History

Johns Hopkins School of Medicine

United States

PHD :: Biochemistry, Cell and Molecular Biology

Publications

Lucero Martínez-Fructuoso, S J Ryan Arends, Vitor F Freire, Jason R Evans, Sean DeVries, Brian D Peyser, Rhone K Akee, Christopher C Thornburg, Rohitesh Kumar, Susan Ensel, Gina M Morgan, Grant D McConachie, Nathan Veeder, Leonard R Duncan, Tanja Grkovic, Barry R Oâ Keefe
Screen for New Antimicrobial Natural Products from the NCI Program for Natural Product Discovery Prefractionated Extract Library. ACS infectious diseases (2023)
Yue Zhan, Xiaolei Zhou, Sylvain Peuget, Madhurendra Singh, Brian D Peyser, Zhimin Fan, Galina Selivanova
Decreased DNA Damage and Improved p53 Specificity of RITA Analogs. Molecular cancer therapeutics 21 (10) (2022)
Brian D Peyser, Ann Hermone, Joseph M Salamoun, James C Burnett, Melinda G Hollingshead, Connor F McGrath, Rick Gussio, Peter Wipf
Specific RITA Modification Produces Hyperselective Cytotoxicity While Maintaining In Vivo Antitumor Efficacy. Molecular cancer therapeutics 18 (10) (2019)

Brian D Peyser.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Brian D Peyser